| Heather R Martin, DO | |
|
315 S Osteopathy Ave, Kirksville, MO 63501-6401 | |
| (660) 626-2222 | |
| Not Available |
| Full Name | Heather R Martin |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 11 Years |
| Location | 315 S Osteopathy Ave, Kirksville, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497161517 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2014023506 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northeast Regional Medical Center | Kirksville, MO | Hospital |
| Scotland County Hospital | Memphis, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northeast Missouri Health Council Inc | 1658280805 | 21 |
News Archive
A biological pathway that transforms normal cells into aggressive tumors has been discovered by researchers at Cleveland Clinic's Lerner Research Institute.
Intellect Neurosciences, Inc. a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has locked the database of the Company's Phase 1b clinical trial for its lead Alzheimer's candidate, OXIGON™ (OX1).
Individuals with this altered gene have hereditary hypertension (high blood pressure) and at the same time a skeletal malformation called brachydactyly type E, which is characterized by unusually short fingers and toes. The effect on blood pressure is so serious that - if left untreated - it most often leads to death before age fifty.
Researchers discovered a new, key component in the spread of lung cancer as well as a likely way to block it with drugs now in clinical trial. The study was published today (Monday, March 14) in the Journal of Clinical Investigation.
People tried to avoid a healthcare situation and in doing so, they propagated it through the community because instead of being in isolation they remained around the family group and relied on usual cultural health remedies...
› Verified 4 days ago
| Entity Name | Northeast Missouri Health Council Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881730893 PECOS PAC ID: 1658280805 Enrollment ID: O20040107000173 |
News Archive
A biological pathway that transforms normal cells into aggressive tumors has been discovered by researchers at Cleveland Clinic's Lerner Research Institute.
Intellect Neurosciences, Inc. a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has locked the database of the Company's Phase 1b clinical trial for its lead Alzheimer's candidate, OXIGON™ (OX1).
Individuals with this altered gene have hereditary hypertension (high blood pressure) and at the same time a skeletal malformation called brachydactyly type E, which is characterized by unusually short fingers and toes. The effect on blood pressure is so serious that - if left untreated - it most often leads to death before age fifty.
Researchers discovered a new, key component in the spread of lung cancer as well as a likely way to block it with drugs now in clinical trial. The study was published today (Monday, March 14) in the Journal of Clinical Investigation.
People tried to avoid a healthcare situation and in doing so, they propagated it through the community because instead of being in isolation they remained around the family group and relied on usual cultural health remedies...
› Verified 4 days ago
| Entity Name | Northeast Missouri Health Council Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104829498 PECOS PAC ID: 1658280805 Enrollment ID: O20040112000061 |
News Archive
A biological pathway that transforms normal cells into aggressive tumors has been discovered by researchers at Cleveland Clinic's Lerner Research Institute.
Intellect Neurosciences, Inc. a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has locked the database of the Company's Phase 1b clinical trial for its lead Alzheimer's candidate, OXIGON™ (OX1).
Individuals with this altered gene have hereditary hypertension (high blood pressure) and at the same time a skeletal malformation called brachydactyly type E, which is characterized by unusually short fingers and toes. The effect on blood pressure is so serious that - if left untreated - it most often leads to death before age fifty.
Researchers discovered a new, key component in the spread of lung cancer as well as a likely way to block it with drugs now in clinical trial. The study was published today (Monday, March 14) in the Journal of Clinical Investigation.
People tried to avoid a healthcare situation and in doing so, they propagated it through the community because instead of being in isolation they remained around the family group and relied on usual cultural health remedies...
› Verified 4 days ago
| Entity Name | Northeast Missouri Health Council Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104829498 PECOS PAC ID: 1658280805 Enrollment ID: O20040430000892 |
News Archive
A biological pathway that transforms normal cells into aggressive tumors has been discovered by researchers at Cleveland Clinic's Lerner Research Institute.
Intellect Neurosciences, Inc. a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has locked the database of the Company's Phase 1b clinical trial for its lead Alzheimer's candidate, OXIGON™ (OX1).
Individuals with this altered gene have hereditary hypertension (high blood pressure) and at the same time a skeletal malformation called brachydactyly type E, which is characterized by unusually short fingers and toes. The effect on blood pressure is so serious that - if left untreated - it most often leads to death before age fifty.
Researchers discovered a new, key component in the spread of lung cancer as well as a likely way to block it with drugs now in clinical trial. The study was published today (Monday, March 14) in the Journal of Clinical Investigation.
People tried to avoid a healthcare situation and in doing so, they propagated it through the community because instead of being in isolation they remained around the family group and relied on usual cultural health remedies...
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Heather R Martin, DO 315 S Osteopathy Ave, Kirksville, MO 63501-6401 Ph: (660) 626-2222 | Heather R Martin, DO 315 S Osteopathy Ave, Kirksville, MO 63501-6401 Ph: (660) 626-2222 |
News Archive
A biological pathway that transforms normal cells into aggressive tumors has been discovered by researchers at Cleveland Clinic's Lerner Research Institute.
Intellect Neurosciences, Inc. a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has locked the database of the Company's Phase 1b clinical trial for its lead Alzheimer's candidate, OXIGON™ (OX1).
Individuals with this altered gene have hereditary hypertension (high blood pressure) and at the same time a skeletal malformation called brachydactyly type E, which is characterized by unusually short fingers and toes. The effect on blood pressure is so serious that - if left untreated - it most often leads to death before age fifty.
Researchers discovered a new, key component in the spread of lung cancer as well as a likely way to block it with drugs now in clinical trial. The study was published today (Monday, March 14) in the Journal of Clinical Investigation.
People tried to avoid a healthcare situation and in doing so, they propagated it through the community because instead of being in isolation they remained around the family group and relied on usual cultural health remedies...
› Verified 4 days ago
Karen A Sylvara, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 502 S Baltimore St, Kirksville, MO 63501 Phone: 660-665-5570 Fax: 660-665-2898 | |
Dr. Katherine Lynne Holbrook, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 800 W Jefferson St, Kirksville, MO 63501 Phone: 660-626-2223 | |
Molly Christine Thompson, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 315 S Osteopathy Ave, Kirksville, MO 63501 Phone: 660-785-1000 | |
Dr. Stephanie Gonzales, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 315 S Osteopathy Ave, Kirksville, MO 63501 Phone: 660-785-1000 | |
Dr. James L Bowers, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1415 E Scott St, Kirksville, MO 63501 Phone: 660-665-1767 Fax: 660-665-1767 | |
Dr. Ronald Leland Phillips, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Crown Dr, Suite 200, Kirksville, MO 63501 Phone: 660-665-3838 Fax: 660-665-0130 | |
Dr. Steven R Lyons, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 W Jefferson St, Kirksville, MO 63501 Phone: 660-785-1000 |